Recent increases in drug prices have become a central issue for consumers, media, and Congress. This panel, which includes WilmerHale Partner Mark Ford, will address the causes of these increases and the role of competition law in this arena. Why do we see price spikes? What if any role does competition law play to prevent price spikes? If price spikes are not subject to antitrust enforcement, what is the role for public policy?
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
